You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The pipeline, called IMPACT, pinpointed genetic variants in lung cancer and melanoma patients and matched them to targeted drugs.
In Genome Research this week: sequencing approach to detect large CNVs, method to find CRISPR-Cas9 nuclease targets, and more.
Researchers identified prognostically relevant glioma subtypes by incorporating genetic, epigenetic, and protein data for 1,122 diffuse glioma tumors.
The results showed that syndromic forms of autism are more likely when children have alterations of genes in the mGluR pathway.
In PNAS this week: identification of human follicle mite lineages using mtDNA, copy number expansions in cattle NK-lysin gene, and more.
Using a suite of genomic tools, the Cancer Genome Atlas Research Network characterized primary prostate cancers.
Members of TCGA characterized papillary renal cell carcinomas, uncovering two main tumor groups and several more prognostically informative subtypes.
In Science this week: human population copy number analysis, and more.
The method detects somatic copy number alterations in whole-exome datasets without requiring input from users and irrespective of sequencing platform.
More than 10 percent of individuals in an unselected population carried recurrent syndrome-associated CNVs or rare autosomal CNVs with potential ties to cognitive ability.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.